Purchases and Sales Made in Q3 2022 in Regencell Bioscience Holdings LTD (RGC)
This table provides information about the institutional ownership of Regencell Bioscience Holdings LTD (RGC) during Q3 2022. The information is specifically focused on institutions that hold shares of Regencell Bioscience Holdings Ltd.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
78+ 52.35% |
$2.1K - $3.18K
|
227
$1.16K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-175- 24.2% |
$4.71K - $7.14K
|
548
$2.81K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-206- 35.64% |
$5.55K - $8.4K
|
372
$1.9K
|